Lunai Bioworks Inc. Voluntarily Withdraws from Nasdaq Listing

Lunai Bioworks Inc. received notification from Nasdaq that it no longer complies with Nasdaq Listing Rule 5550(b)(1), which requires a minimum stockholders' equity of $2,500,000. The company reported a stockholders' deficit of $(9,024,946) in its Annual Report for the fiscal year ended June 30, 2026. The company has approved the voluntary withdrawal of its common stock from listing on Nasdaq.

Nasdaq staff determined that the company's securities should be delisted due to its financial condition. The company chose to voluntarily withdraw its stock rather than contest the staff determination, concluding that the cost of continued listing was not justified.